期刊
EXPERT OPINION ON THERAPEUTIC PATENTS
卷 33, 期 3, 页码 193-209出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/13543776.2023.2176219
关键词
Chagas disease; patent; Trypanosoma cruzi; innovation; treatment
Vicious cycle, patent research, insufficient treatment methods.
IntroductionChagas disease is a neglected, endemic disease in 21 countries, spreading to non-endemic countries too. Like other neglected diseases affecting primarily low- and middle-income countries, low investment and the absence of new chemical entities from the industry occurred. Increased knowledge about the parasite, drug targets, and vector control has been observed, but this was not translated into new drugs. The partnerships of pharmaceutical companies with academies and consolidated networks to increment the new drugs and treatment research in Chagas disease are shown. The current review analyzes in detail the patents dealing with compounds candidates for new drugs and treatment. The patent search was performed using Orbit Intelligence (R) software in the 2001-2021 period.Areas coveredThe author focused specifically on patents for the treatment, the new candidates disclosed in the patents, and the barriers to innovation.Expert opinionPatents in Chagas disease have been increasing in the last years, although they do not bring new compounds to an effective treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据